https://www.indianpharmapost.com/bms-cobenfy-sees-steady-start-eyes-stronger-growth-ahead-181062025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-digital-health-launches-vitalyfe-181222025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/medcognetics-and-laurel-bridge-unite-to-revolutionize-breast-cancer-screening-with-secure-ai-workflow-181212025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/restorixhealth-acquires-cutiscare-to-expands-wound-care-portfolio-181202025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/alexion-highlights-breakthrough-c5-inhibition-advances-in-gmg-at-2025-aanem-and-mgfa-scientific-sessions-181192025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/shaquille-oneal-and-lilly-join-forces-to-tackle-sleep-apnea-awareness-181182025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/eu-approves-alexions-koselugo-to-treat-adults-with-neurofibromatosis-type-1-tumours-181172025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fujifilm-india-unveils-fw500-advancing-biochemistry-innovation-in-diagnostics-181162025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/indias-healthcare-and-pharma-sectors-recorded-a-total-of-72-transactions-valued-at-us-35-billion-in-q3-2025-grant-thornton-bharat-181152025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/lillys-omvoh-shows-rapid-and-lasting-relief-from-bowel-urgency-in-ulcerative-colitis-patients-181142025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-signs-745-million-licensing-agreement-with-empirico-for-novel-respiratory-sirna-therapy-181132025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvies-rinvoq-shows-promise-in-vitiligo-phase-3-trials-181122025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-issues-warning-letter-to-philips-over-manufacturing-and-quality-system-deficiencies-181112025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-grants-breakthrough-status-to-augurexs-spinestat-test-to-advance-early-axspa-diagnosis-181102025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/aldeyra-refocuses-pipeline-on-next-gen-rasp-modulators-despite-positive-phase-ii-success-181092025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-rejects-regenerons-eylea-hd-pre-filled-syringe-application-amid-manufacturing-setbacks-181082025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/mercks-capvaxive-shows-strong-momentum-amid-industry-vaccine-decline-181072025-10-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-launches-everolimus-tablets-1-mg-181232025-10-31T00:00:00+05:30always0.9